Primary Intracranial Alveolar Soft Part Sarcoma: Systematic Review
Surgical resection remains the primary treatment. Transcription Factor E3 immunoreactivity supports diagnosis. Occult extracranial disease should be excluded. Long-term monitoring is essential due to the indolent course of primary intracranial alveolar soft-part sarcoma.
Authors
- Tariq Imran Khokhar (ORCID: https://orcid.org/0009-0008-1446-8575)
- Katharine J. Drummond (ORCID: https://orcid.org/0000-0002-8152-2120)
- Haseeb Mehmood Qadri (ORCID: https://orcid.org/0000-0003-0675-9934)
- Asif Bashir
- Muhammad Awais Ahmad (ORCID: https://orcid.org/0000-0003-0931-0542)
- Ali Raza (ORCID: https://orcid.org/0009-0000-3577-4231)
- Muhammad Imran (ORCID: https://orcid.org/0009-0001-0580-453X)
- Hossam Saeed (ORCID: https://orcid.org/0000-0003-2895-5688)
Institutions
- Jinnah Postgraduate Medical Center (PK)
- The Royal Melbourne Hospital (AU)
- Punjab Institute of Cardiology (PK)
- Allama Iqbal Medical College (PK)
- Lahore General Hospital (PK)
- Institute of Management Sciences Lahore (PK)
- Shifa International Hospital (PK)
- Post Graduate Medical Institute (PK)
- The FRAM Centre (NO)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-12-09
- DOI
- https://doi.org/10.12669/pjms.41.13(pins-nnos).13472
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Missouri